Leslie Chong

Cure Brain Cancer Foundation is a non-profit organization based in Australia that is dedicated to funding innovative brain cancer research. The private company is based in Sydney, Australia. The foundation has invested over $30 million into brain cancer research, including clinical trials and pre-clinical research efforts across pediatric and adult brain cancers. The foundation passionately forges research collaborations, brings world-class clinical trials, and gives people with brain cancer greater access to innovative new treatments. The foundation's mission is to unite the community and rapidly increase brain cancer survival, improving the quality of life for people impacted by the disease, with a vision to ultimately find a cure for brain cancer. The Australian company was founded in 2001. Lance Kawaguchi has been the CEO of the company since 2021.

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.